Abstract
Fragment-based drug discovery (FBDD) needs a biophysical assay to complement, or even replace, biochemical screening. NMR is the best choice for this because NMR delivers many different types of data that impacts medicinal chemistry decisions. There are a multitude of different NMR methods which can be employed to these ends. The choice of which method to use will be different for every need. We discuss the different methods, the data they produce, and how they are best utilized in a FBDD setting.
Keywords: NMR, Fragment, Screening, protein-based, ligand-based
Current Topics in Medicinal Chemistry
Title: Practical Aspects of NMR-based Fragment Discovery
Volume: 7 Issue: 16
Author(s): Edward R. Zartler and Huaping Mo
Affiliation:
Keywords: NMR, Fragment, Screening, protein-based, ligand-based
Abstract: Fragment-based drug discovery (FBDD) needs a biophysical assay to complement, or even replace, biochemical screening. NMR is the best choice for this because NMR delivers many different types of data that impacts medicinal chemistry decisions. There are a multitude of different NMR methods which can be employed to these ends. The choice of which method to use will be different for every need. We discuss the different methods, the data they produce, and how they are best utilized in a FBDD setting.
Export Options
About this article
Cite this article as:
Zartler R. Edward and Mo Huaping, Practical Aspects of NMR-based Fragment Discovery, Current Topics in Medicinal Chemistry 2007; 7 (16) . https://dx.doi.org/10.2174/156802607782341055
DOI https://dx.doi.org/10.2174/156802607782341055 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Therapeutic Potential of Purinergic Receptors in Alzheimer’s Disease and Promising Therapeutic Modulators
Mini-Reviews in Medicinal Chemistry The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives
Endocrine, Metabolic & Immune Disorders - Drug Targets Development of New Drugs that Act Through Membrane Receptors and Involve an Action of Inverse Agonism
Recent Patents on CNS Drug Discovery (Discontinued) Positron Emitting Tracers in Pre-Clinical Drug Development
Current Radiopharmaceuticals The Role of Melatonin in the Immuno-Neuro-Psychology of Mental Disorders
Recent Patents on CNS Drug Discovery (Discontinued) The Benefits of Exercise and Metabolic Interventions for the Prevention and Early Treatment of Alzheimer's Disease
Current Alzheimer Research Discrimination Between Producing Regions of Brazilian Propolis by UV-VIS Spectroscopy and Partial Least Squares Discriminant Analysis
Current Analytical Chemistry Application of Multimodal MR Imaging on Studying Alzheimer's Disease: A Survey
Current Alzheimer Research The Beneficial Effect of Rice Bran Extract Against Rotenone-Induced Experimental Parkinson’s Disease in Rats
Current Molecular Pharmacology Monoclonal Antibodies in the Treatment of Multiple Sclerosis
Current Medicinal Chemistry Editorial [Hot Topic: Recent Advances in Stroke: Molecular Mechanisms, Approaches, and Treatments (Guest Editor: Xin Wang)]
Central Nervous System Agents in Medicinal Chemistry Impact of Sex Hormone Metabolism on the Vascular Effects of Menopausal Hormone Therapy in Cardiovascular Disease
Current Drug Metabolism Vascular Protection to Increase the Safety of Tissue Plasminogen Activator for Stroke
Current Pharmaceutical Design Thriving, Managing, and Struggling: A Mixed Methods Study of Adolescent African Refugees’ Psychosocial Adjustment
Adolescent Psychiatry Cysteine-, Methionine- and Seleno-Cysteine-Proline Chimeras: Synthesis and Their Use in Peptidomimetics Design
Current Bioactive Compounds Prophylaxis of Cancer
Current Cancer Therapy Reviews Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders
Current Pharmaceutical Design Recent Progress in the Development of Small Molecule c-Met Inhibitors
Current Topics in Medicinal Chemistry Impact and Therapeutic Potential of PPARs in Alzheimers Disease
Current Neuropharmacology Novel Antidepressant Drugs, Arterial Hypertension and Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery